Cancer is classically a disease of the elderly, yet all too often the special needs of older patients seem to be ignored. Routine use of screening to distinguish patients healthy enough to receive standard therapy [more]
Hormonal treatment remains a main stay of systemic therapy for prostate cancer despite recent developments in chemotherapy and intensive research with targeted drugs and immunotherapy. Its efficacy in palliative management of advanced disease has prompted [more]
Targeted therapies seek to close down signalling pathways that allow tumours to prosper. But these pathways may also be vital to other clinical functions. With rising concern about collateral cardiac damage from cancer treatment comes [more]
Silvio Monfardini’s great contribution to oncology has been raising the standard of care for older patients. His story is a shining example of what can be achieved when scientific rigour is combined with a deep-rooted [more]
When it comes to cancer, newspapers tend to home in on tragic stories of young mothers or children. The big story of the explosion of cancer cases among the elderly and the urgent need for [more]
The adoptive transfer of antigen-specific CD4+ cells is a feasible treatment for cancer and provides critical insight into immune mechanisms involved in durable clinical responses. Download full article
Postoperative radiotherapy with or without chemotherapy remains part of the standard treatment regimen to improve locoregional control for patients with head and neck cancer who have adverse pathologic factors after surgery. Whether an overall survival [more]
Selected reports edited by Janet Fricker Download full article
Cancer may be caused by stem cells gone bad. If that proves to be correct, it should revolutionise treatment. Download full article